• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种由淋巴细胞产生的血管通透性因子。I. 肾病综合征患者的验证。

A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

作者信息

Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B

出版信息

Biomedicine. 1975 Feb 10;23(1):37-40.

PMID:1174637
Abstract

P.H.A. and Concanavalin A stimulated lymphocytes culture supernatants were comparatively studied in 23 volontary normals and in 46 patients with nephrotic syndrome. Intradermal injections to guinea-pig demonstrated a permeability increasing and pro-inflammatory factor. Vascular permeability (immediate reaction) is determinated by blue Evans technique. Delayed reaction is assesed by the cutaneous inflammatory process (erythema, induration); pathologically it is defined as polymorphonuclear and mononuclear infiltration. Differences are highly significant between nephrotic patients and normal subjects. This biological activity is not observed with control supernatants (medium plus normal human serum and P.H.A. or Conca A). Positive results were also found with M.E.M. eagle culture supernatants of nephrotic stimulated lymphocytes. To date lymphokines have been studied especially in animals. In human, they have been found only after concentration. Variations in lymphokine production may be present in some pathologic states.

摘要

对23名健康志愿者和46名肾病综合征患者的PHA和伴刀豆球蛋白A刺激的淋巴细胞培养上清液进行了比较研究。对豚鼠进行皮内注射显示出一种通透性增加和促炎因子。血管通透性(即时反应)通过伊文思蓝技术测定。迟发性反应通过皮肤炎症过程(红斑、硬结)进行评估;病理上定义为多形核和单核浸润。肾病患者与正常受试者之间的差异非常显著。对照上清液(培养基加正常人血清以及PHA或伴刀豆球蛋白A)未观察到这种生物活性。肾病刺激淋巴细胞的伊格尔MEM培养基培养上清液也得到了阳性结果。迄今为止,淋巴因子尤其在动物中得到了研究。在人类中,仅在浓缩后才发现它们。某些病理状态下可能存在淋巴因子产生的变化。

相似文献

1
A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.一种由淋巴细胞产生的血管通透性因子。I. 肾病综合征患者的验证。
Biomedicine. 1975 Feb 10;23(1):37-40.
2
Lymphokine 'skin reactive factor' (SRF) and the nephrotic syndrome.淋巴因子“皮肤反应因子”(SRF)与肾病综合征
Bibl Anat. 1975;13:331-4.
3
Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.伴刀豆球蛋白A刺激的人淋巴细胞产生的血管通透性因子的物理化学特性
J Immunol. 1977 Oct;119(4):1230-4.
4
Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.白细胞介素-15和白细胞介素-12对正常人和肾病综合征患者外周血单个核细胞释放血管通透性因子具有相加作用。
Clin Nephrol. 1999 Jul;52(1):10-8.
5
Vascular permeability factor produced by lymphocytes of patients with nephrotic syndrome.肾病综合征患者淋巴细胞产生的血管通透因子。
Adv Nephrol Necker Hosp. 1981;10:315-32.
6
Vascular permeability increasing factor (VPF) in IgA nephropathy.
Clin Nephrol. 1982 Oct;18(4):165-7.
7
[Vascular permeability factor in the supernatant of lymphocyte cultures in subjects with nephrotic syndrome].[肾病综合征患者淋巴细胞培养上清液中的血管通透性因子]
J Urol Nephrol (Paris). 1975 Apr-May;81(4-5):344-8.
8
[Factor of capillary permeability in lymphocyte culture supernatant in nephrotic syndromes. Preliminary results].[肾病综合征淋巴细胞培养上清液中的毛细血管通透性因子。初步结果]
Nouv Presse Med. 1973 Jun 23;2(25):1719.
9
Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF).局灶节段性肾小球硬化中肾小球通透因子(GPF)的研究以及GPF与血管通透因子(VPF)之间的关系。
Clin Nephrol. 1999 Nov;52(5):278-84.
10
Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.伴刀豆球蛋白A刺激的淋巴细胞上清液中的电荷减少淋巴细胞因子活性:初步生物学和生化特性分析
Biomed Biochim Acta. 1984;43(1):57-65.

引用本文的文献

1
Real-World Weekly Efficacy Analysis of Faricimab in Patients with Age-Related Macular Degeneration.法西单抗治疗年龄相关性黄斑变性患者的真实世界每周疗效分析
Bioengineering (Basel). 2024 May 10;11(5):478. doi: 10.3390/bioengineering11050478.
2
Swollen Feet: Considering the Paradoxical Roles of Interleukins in Nephrotic Syndrome.足部肿胀:探讨白细胞介素在肾病综合征中的矛盾作用
Biomedicines. 2024 Mar 26;12(4):738. doi: 10.3390/biomedicines12040738.
3
"Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
特发性微小病变肾病综合征:足细胞之谜即将揭晓。
Am J Physiol Renal Physiol. 2023 Dec 1;325(6):F685-F694. doi: 10.1152/ajprenal.00219.2023. Epub 2023 Oct 5.
4
Disease Recurrence-The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis.疾病复发——原发性局灶节段性肾小球硬化症肾移植的达摩克利斯之剑。
Front Immunol. 2019 Jul 17;10:1669. doi: 10.3389/fimmu.2019.01669. eCollection 2019.
5
Renal toxicities associated with pembrolizumab.与帕博利珠单抗相关的肾毒性。
Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 9.
6
Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics.肾病综合征:水肿形成及其利尿剂治疗
Front Physiol. 2019 Jan 15;9:1868. doi: 10.3389/fphys.2018.01868. eCollection 2018.
7
Idiopathic Nephrotic Syndrome: Characteristics and Identification of Prognostic Factors.特发性肾病综合征:特征及预后因素的识别
J Clin Med. 2018 Sep 9;7(9):265. doi: 10.3390/jcm7090265.
8
Does Zika virus infection induce prolonged remissions in children with idiopathic nephrotic syndrome?寨卡病毒感染会使特发性肾病综合征患儿长期缓解吗?
Pediatr Nephrol. 2017 May;32(5):897-900. doi: 10.1007/s00467-017-3588-5. Epub 2017 Feb 7.
9
Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?足细胞中白细胞介素-2受体的激活:特发性肾病综合征中足细胞损伤的潜在机制?
PLoS One. 2016 Jul 7;11(7):e0157907. doi: 10.1371/journal.pone.0157907. eCollection 2016.
10
Pathogenesis of minimal change nephrotic syndrome: an immunological concept.微小病变型肾病综合征的发病机制:一种免疫学概念。
Korean J Pediatr. 2016 May;59(5):205-11. doi: 10.3345/kjp.2016.59.5.205. Epub 2016 May 31.